Ignite Creation Date:
2025-12-24 @ 11:38 PM
Ignite Modification Date:
2026-01-02 @ 1:15 PM
Study NCT ID:
NCT01716156
Status:
COMPLETED
Last Update Posted:
2018-09-24
First Post:
2012-10-25
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study of Different Durations of Treatment With Grazoprevir (MK-5172) in Combination With Ribavirin in Participants With Chronic Hepatitis C (MK-5172-039)
Sponsor:
Merck Sharp & Dohme LLC
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2013-01-18
Start Date Type:
ACTUAL
Primary Completion Date:
2013-12-09
Primary Completion Date Type:
ACTUAL
Completion Date:
2014-03-12
Completion Date Type:
ACTUAL
First Submit Date:
2012-10-25
First Submit QC Date:
None
Study First Post Date:
2012-10-29
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2016-02-03
Results First Submit QC Date:
None
Results First Post Date:
2016-03-04
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-08-23
Last Update Post Date:
2018-09-24
Last Update Post Date Type:
ACTUAL